Hello Malaysian Mooers! We are excited to announce that our FPX Express Deposit is now available!
From now on, choose the FPX transfer method and experience the funds arriving within 5 minutes, making your trading experience smoother~
📚 Learn how to use FPX to deposit funds in one minute
> Click here to learn more about this feature <
🗳️ Quick poll: Are you ready to experience FPX Express Deposit to trade
Discuss your i...

$TGUAN (7034.MY)$ $BPPLAS (5100.MY)$ $SLP (7248.MY)$
In March, SCIENTX announced its earnings. Although the packaging business's profit declined year-on-year, the outlook mentions a future recovery. According to investment bank tracking, TGUAN also mentioned that demand will start recovering this year.
BPPLAS has already achieved a 15.4% year-on-year growth in net income in FY2023, making it have the most aggressive stock price increase this year. Today, SLP announced its latest performance, with net income hitting a new high for 6 quarters, growing by 63.1% year-on-year. While the revenue growth is not significant, the improvement in the Product mix and the decline in raw material costs have significantly increased the Margin.
2023 was a challenging year for many manufacturing industries, primarily due to excessive inventory from previous customers, leading to destocking last year. This year, the situation has improved, exports are also beginning to recover, and the packaging industry is expected to have a good year.
It is expected that the earnings call of the above 4 packaging companies will turn upwards from the bottom. SCIENTX is approaching the long-term market cap of RM10 billion in a strong industry and packaging business recovery environment.
Profit is expected to recover, and the stock price has been on the rise for the past month. As long as the profit meets the standard, I believe the value of these companies will be recognized by more investors. Let's inspire each other.

$Tesla (TSLA.US)$ Quick summary:
- Elon announced an affordable model by early 2025 (possibly end 2024).
- Q1 profit, revenue, and margins drop way below forecasts.
- Global vehicle inventory increases to 28 days (from 15 days).
- TSLA rallied upon optimism on new models, despite an underwhelming quarter.
Tesla recently reported a significant 55% drop in Q1 profits and a 9% decline in revenue, and it caused mixed emotions within investors. However, during the earnin...

After years of researches and studies , finally TauRx released the full results and presentation of Phase 3 clinical studies of the flagship medicine named HMTM .
$GENTING (3182.MY)$ is having a 20% stake in TauRx , in which it is currently not making profits as the principal product HMTM is still under development and yet to be commercialized.
With the data released from the clinical trials , it is likely that TauRx’s HMTM will get the approvals from authority of key...